Rhenman & Partners Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-310,000	Closed	-$3.85M	–	92
2022 Q2	$3.85M	Buy	310,000 +60,700	+24%	+$670K	0.44%	61
2022 Q1	$3.32M	Sell	249,300 -700	-0.3%	-$9.39K	0.33%	74
2021 Q4	$4.02M	Hold	250,000	–	–	0.27%	79
2021 Q3	$5.61M	Hold	250,000	–	–	0.39%	70
2021 Q2	$5.69M	Buy	250,000 +25,000	+11%	+$526K	0.39%	77
2021 Q1	$4.63M	Buy	225,000 +25,000	+13%	+$569K	0.32%	76
2020 Q4	$5.52M	Sell	200,000 -180,000	-47%	-$3.5M	0.45%	65
2020 Q3	$5.34M	Buy	380,000 +230,000	+153%	+$4.28M	0.47%	62
2020 Q2	$3.09M	Buy	+150,000	New	+$2.04M	0.33%	75

Other funds holding MYOV

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Rhenman & Partners Asset Management's MYOV Position: Q3 2022 in Review

Rhenman & Partners Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 310,000 shares — an estimated $3.85M sold.

Rhenman & Partners Asset Management first reported a position in MYOV in Q2 2020 and held it in 9 quarters. The position peaked at $5.69M in Q2 2021. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

Rhenman & Partners Asset Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
Rhenman & Partners Asset Management sold 310,000 Myovant Sciences Ltd. shares in Q3 2022, an estimated $3.85M.
Rhenman & Partners Asset Management first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 9 quarters.
Rhenman & Partners Asset Management's Myovant Sciences Ltd. position peaked at $5.69M in Q2 2021.
98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.